Skip to content

Novavax NVAX FX Effect on Cash

FX Effect on Cash at other companies

Moderna logo
ModernaMRNA
$1M
Roivant Sciences logo
Roivant SciencesROIV
$1.32M
Merck & Co. logo
Merck & Co.MRK
-$19M-112%
Vaxcyte, Inc. logo
Vaxcyte, Inc.PCVX
-$664K-157%
ALN
Alnylam PharmaceuticalsALNY
-$7.06M-150%
Gilead Sciences logo
Gilead SciencesGILD
-$11M-158%

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+41.0%
Enterprise value$1.53B+83.6%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's FX effect on cash?
Novavax (NVAX) reported FX effect on cash of -$18K in Q1 2026.
How has Novavax's FX effect on cash changed year-over-year?
Novavax's FX effect on cash increased by 98.1% year-over-year, from -$930K to -$18K.
What is the long-term trend for Novavax's FX effect on cash?
Over 2 years (2022 to 2024), Novavax's FX effect on cash has grown at a 31.4% compound annual growth rate (CAGR), from $4.52M to -$7.8M.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.